Nicolas Williet

3.5k total citations
70 papers, 2.2k citations indexed

About

Nicolas Williet is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Nicolas Williet has authored 70 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Genetics, 28 papers in Surgery and 28 papers in Epidemiology. Recurrent topics in Nicolas Williet's work include Inflammatory Bowel Disease (32 papers), Microscopic Colitis (21 papers) and Pancreatic and Hepatic Oncology Research (13 papers). Nicolas Williet is often cited by papers focused on Inflammatory Bowel Disease (32 papers), Microscopic Colitis (21 papers) and Pancreatic and Hepatic Oncology Research (13 papers). Nicolas Williet collaborates with scholars based in France, United States and Australia. Nicolas Williet's co-authors include Laurent Peyrin‐Biroulet, Xavier Roblin, P. Cacoub, William J. Sandborn, Stéphane Paul, Jean–Marc Phelip, Stéphane Nancey, Abderrahim Oussalah, Bernard Flourié and Gilles Boschetti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Nicolas Williet

70 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Williet France 22 1.3k 1.1k 585 345 328 70 2.2k
Simone Saibeni Italy 28 1.1k 0.8× 809 0.7× 850 1.5× 299 0.9× 165 0.5× 99 2.3k
Paul J. Healey United States 11 1.3k 1.0× 870 0.8× 364 0.6× 486 1.4× 311 0.9× 29 1.9k
J Y Mary France 17 1.4k 1.1× 1.1k 1.0× 734 1.3× 196 0.6× 184 0.6× 31 2.1k
Daniel A. Sussman United States 23 1.1k 0.8× 908 0.8× 563 1.0× 344 1.0× 646 2.0× 113 2.3k
Andreas Kapsoritakis Greece 25 539 0.4× 431 0.4× 609 1.0× 250 0.7× 314 1.0× 66 1.7k
Philippe Vergauwe Belgium 16 812 0.6× 794 0.7× 536 0.9× 123 0.4× 473 1.4× 49 1.6k
Meena Thayu United States 25 639 0.5× 532 0.5× 307 0.5× 243 0.7× 473 1.4× 59 2.0k
Yago González‐Lama Spain 19 989 0.8× 798 0.7× 402 0.7× 192 0.6× 66 0.2× 51 1.4k
Jean‐François Rahier Belgium 21 741 0.6× 581 0.5× 344 0.6× 394 1.1× 607 1.9× 60 2.0k
Ole Høie Norway 21 1.9k 1.5× 1.7k 1.5× 1.0k 1.7× 192 0.6× 480 1.5× 36 2.7k

Countries citing papers authored by Nicolas Williet

Since Specialization
Citations

This map shows the geographic impact of Nicolas Williet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Williet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Williet more than expected).

Fields of papers citing papers by Nicolas Williet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Williet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Williet. The network helps show where Nicolas Williet may publish in the future.

Co-authorship network of co-authors of Nicolas Williet

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Williet. A scholar is included among the top collaborators of Nicolas Williet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Williet. Nicolas Williet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dusetti, Nelson, Jean‐Baptiste Bachet, Brice Chanez, et al.. (2025). Medical management of pancreatic cancer: from personalization to broadening treatment strategies. Cancer Treatment Reviews. 138. 102973–102973. 2 indexed citations
2.
Camus, Marine, David Karsenti, Jonathan Lévy, et al.. (2024). Success rate of fiducial marker placement for treatment of esophageal or rectal cancers: a prospective multicenter study (FIDECHO study) (with video). Gastrointestinal Endoscopy. 101(3). 570–577. 1 indexed citations
3.
4.
Rousset, Pascal, Nicolas Williet, Laurent Milot, et al.. (2024). Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence. Annals of Surgical Oncology. 31(4). 2378–2390. 6 indexed citations
5.
Williet, Nicolas, Fabrice Caillol, David Karsenti, et al.. (2023). The level of glucose in pancreatic cyst fluid is more accurate than carcinoembryonic antigen to identify mucinous tumors: A French multicenter study. Endoscopic Ultrasound. 12(4). 377–381. 6 indexed citations
6.
Edeline, Julien, Julie Henriques, Héloïse Bourien, et al.. (2023). 119P Management of biliary tract cancers in older patients: A French multicenter cohort study. Annals of Oncology. 34. S226–S227. 1 indexed citations
7.
Roth, Gaël S., Yohan Fayet, Françoise Ducimetière, et al.. (2022). Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort. Cancers. 14(21). 5413–5413. 1 indexed citations
8.
Hautefeuille, Vincent, Louis de Mestier, Clélia Coutzac, et al.. (2022). Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study. International Journal of Cancer. 152(9). 1894–1902. 2 indexed citations
9.
Pointet, Anne‐Laure, David Tougeron, Simon Pernot, et al.. (2019). Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study. Clinics and Research in Hepatology and Gastroenterology. 44(3). 295–301. 13 indexed citations
10.
Boschetti, Gilles, Xavier Roblin, Nicolas Williet, et al.. (2019). Concentrations of Ustekinumab During Induction Therapy Associate With Remission in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology. 17(12). 2610–2612. 39 indexed citations
11.
Williet, Nicolas, Lieven Pouillon, Manoel de Carvalho, et al.. (2018). Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study. Alimentary Pharmacology & Therapeutics. 47(7). 906–912. 87 indexed citations
12.
Nancey, Stéphane, F. Hacard, Nicolas Williet, et al.. (2018). Efficacy and Safety of Infliximab Tolerance Induction in Patients with Inflammatory Bowel Diseases who Experienced Acute Infusion Reactions. Digestive Diseases. 36(6). 417–426. 1 indexed citations
13.
Williet, Nicolas, Radwan Kassir, François Casteillo, et al.. (2018). First Characterization with Ultrasound Contrast Agent of a Fibrovascular Polyp Before Its Endoscopic Resection: A Case Report (with Videos). Clinical Endoscopy. 52(2). 186–190. 1 indexed citations
14.
Roblin, Xavier, Gilles Boschetti, Nicolas Williet, et al.. (2017). Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open‐label, prospective and randomised clinical trial. Alimentary Pharmacology & Therapeutics. 46(2). 142–149. 89 indexed citations
15.
Roblin, Xavier, Gilles Boschetti, Gérard Duru, et al.. (2017). Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 23(11). 2048–2053. 31 indexed citations
16.
Williet, Nicolas, Stéphane Paul, Laurent Peyrin‐Biroulet, & Xavier Roblin. (2015). Pharmacokinetics of Infliximab and Reduction of Treatment for Inflammatory Bowel Diseases. Digestive Diseases and Sciences. 61(4). 990–995. 9 indexed citations
17.
Champigneulle, J., et al.. (2015). The association of autoimmune diseases with pediatric ulcerative colitis does not influence its disease course. Scandinavian Journal of Gastroenterology. 51(1). 33–40. 12 indexed citations
18.
Peyrin‐Biroulet, Laurent, et al.. (2011). Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease. Gut. 60(7). 930–936. 177 indexed citations
19.
Peyrin‐Biroulet, Laurent, Abderrahim Oussalah, Vincent Billioud, et al.. (2011). Urinary tract infections in hospitalized inflammatory bowel disease patients: A 10-year experience. Inflammatory Bowel Diseases. 18(4). 697–702. 21 indexed citations
20.
Williet, Nicolas. (2011). Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma. World Journal of Gastroenterology. 17(17). 2255–2255. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simone Saibeni Breakdown of academic impact, for papers by Paul J. Healey Breakdown of academic impact, for papers by J Y Mary Breakdown of academic impact, for papers by Daniel A. Sussman Breakdown of academic impact, for papers by Andreas Kapsoritakis Breakdown of academic impact, for papers by Philippe Vergauwe Breakdown of academic impact, for papers by Meena Thayu Breakdown of academic impact, for papers by Yago González‐Lama Breakdown of academic impact, for papers by Jean‐François Rahier Breakdown of academic impact, for papers by Ole Høie
Rankless by CCL
2026